The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL...
Date First Received: February 7, 2007
Last Updated: September 5, 2007
Verified by: Innovative Medical, September 2007
Clinical Trial Phase: Phase 4 | Start Date:
Overall Status: Completed
Brief Summary
Condition Keyword(s):
Intervention(s):
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
Study Type: Interventional
Study Design: Randomized, Single Blind, Active Control, Parallel Assignment
Intervention(s) in this Clinical Trial
- Drug: Prednisolone Acetate
- Drug: Ketorolac 0.4%
- Drug: Gatifloxacin 0.3%
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Males or females > 50 years old
- Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal
- IOL.
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion Criteria:
- · Prior use of topical ketorolac
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 50 Years
Maximum Age for this Clinical Trial: N/A
Clinical Trial Sponsor Information
Lead Sponsor: Innovative Medical
Overall Clinical Trial Officials and Contacts
Eric Donnenfeld Principal Investigator Ophthalmic Consultants of Long Island
Additional Information
Information obtained from ClinicalTrials.gov on August 29, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00433225
Study ID Number: 5293
ClinicalTrials.gov Identifier: NCT00433225
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
